Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial Resistance.

Autor: Darlow CA; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom., Docobo-Perez F; Departamento de Microbiología, Universidad de Sevilla, Seville, Spain., Farrington N; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom., Johnson A; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom., McEntee L; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom., Unsworth J; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom., Jimenez-Valverde A; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom., Gastine S; Great Ormond Street Institute of Child Health, University College London, London, United Kingdom., Kolamunnage-Dona R; Department of Health Data Science, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom., de Costa RMA; Global Antibiotic Research and Development Partnership, Geneva, Switzerland., Ellis S; Global Antibiotic Research and Development Partnership, Geneva, Switzerland., Franceschi F; Global Antibiotic Research and Development Partnership, Geneva, Switzerland., Standing JF; Great Ormond Street Institute of Child Health, University College London, London, United Kingdom., Sharland M; Paediatric Infectious Diseases Research Group, St. George's University of London, London, United Kingdom., Neely M; Children's Hospital Los Angeles and the Keck School of Medicine, University of Southern California, Los Angeles, California, USA., Piddock L; Global Antibiotic Research and Development Partnership, Geneva, Switzerland.; Antimicrobials Research Group, School of Immunity and Infection, Institute for Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom., Das S; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom., Hope W; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom.

Publikováno v: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Jun 17; Vol. 65 (7), pp. e0029321. Date of Electronic Publication: 2021 Jun 17.